Caitong International Asset Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.3K Buy
6,293
+4,477
+247% +$21.5K ﹤0.01% 947
2025
Q4
$8.73K Buy
1,816
+634
+54% +$3.07K ﹤0.01% 1161
2025
Q3
$5.98K Buy
1,182
+1,047
+776% +$4.63K ﹤0.01% 1179
2025
Q2
$544 Sell
135
-556
-80% -$1.81K ﹤0.01% 1686
2025
Q1
$1.89K Buy
691
+311
+82% +$1.12K ﹤0.01% 1370
2024
Q4
$1.61K Buy
+380
New +$1.45K ﹤0.01% 1212

Other funds holding SRTA

Caitong International Asset Management's SRTA Position: Q1 2026 in Review

Caitong International Asset Management increased its Strata Critical Medical Inc (SRTA) stake by 247% in Q1 2026, buying an estimated $21.5K and bringing the position to 6,293 shares worth $26.3K. The position accounts for ﹤0.01% of the portfolio, ranked #947.

Caitong International Asset Management first reported a position in SRTA in Q4 2024 and has held it in 6 quarters since. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Caitong International Asset Management held 6,293 shares of Strata Critical Medical Inc worth $26.3K as of Q1 2026.
  • Caitong International Asset Management bought 4,477 Strata Critical Medical Inc shares in Q1 2026, an estimated $21.5K.
  • Strata Critical Medical Inc made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #947 holding.
  • Caitong International Asset Management first reported a position in Strata Critical Medical Inc in Q4 2024 and has held it in 6 quarters since.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.